Tsuyoshi Miyakawa

Tsuyoshi Miyakawa

Auto-generated profile, based on publicly available information

Tsuyoshi Miyakawa

Division of Systems Medical Science, Center for Medical Science, Fujita Health University, Toyoake, Japan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2008 in Nature Neuroscience
Verified
Journal Article
Closed access
IIItaru Imayoshi
Itaru Imayoshi
MSMasayuki Sakamoto
Masayuki Sakamoto
TOToshiyuki Ohtsuka
Toshiyuki Ohtsuka
KTKeizo Takao
Keizo Takao
TMTsuyoshi Miyakawa
Tsuyoshi Miyakawa
RKRyoichiro Kageyama
Ryoichiro Kageyama

22 March 2006 in Nature
Verified
Journal Article
Closed access
PDF file
JAJoseph R. Arron
Joseph R. Arron
MWMonte M. Winslow
Monte M. Winslow
APAlberto Polleri
Alberto Polleri
CCChing-Pin Chang
Ching-Pin Chang
HWHai Wu
Hai Wu
GCGerald R. Crabtree
Gerald R. Crabtree

4 August 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KTKeizo Takao
Keizo Takao
TMTsuyoshi Miyakawa
Tsuyoshi Miyakawa
The use of mice as animal models has long been considered essential in modern biomedical research, but the role of mouse models in research was challenged by a recent report that genomic responses in mouse models poorly mimic human inflammatory diseases. Here we reevaluated the same gene expression datasets used in the previous study by focusing on genes whose expression levels were significantly changed in both humans and mice. Contrary to the previous findings, the gene expression levels in the mouse models showed extraordinarily significant correlations with those of the human conditions (Spearman’s rank correlation coefficient: 0.43–0.68; genes changed in the same direction: 77–93%; P = 6.5 × 10−11 to 1.2 × 10−35). Moreover, meta-analysis of those datasets revealed a number of pathways/biogroups commonly regulated by multiple conditions in humans and mice. These findings demonstrate that gene expression patterns in mouse models closely recapitulate those in human inflammatory conditions and strongly argue for the utility of mice as animal models of human disorders.

28 January 2016 in Molecular Brain
Verified
Journal Article
Open access
PDF file
HSHirotaka Shoji
Hirotaka Shoji
KTKeizo Takao
Keizo Takao
SHSatoko Hattori
Satoko Hattori
TMTsuyoshi Miyakawa
Tsuyoshi Miyakawa
Aging is considered to be associated with progressive changes in the brain and its associated sensory, motor, and cognitive functions. A large number of studies comparing young and aged animals have reported differences in various behaviors between age-cohorts, indicating behavioral dysfunctions related to aging. However, relatively little is known about behavioral changes from young adulthood to middle age, and the effect of age on behavior during the early stages of life remains to be understood. In order to investigate age-related changes in the behaviors of mice from young adulthood to middle age, we performed a large-scale analysis of the behavioral data obtained from our behavioral test battery involving 1739 C57BL/6J wild-type mice at 2–12 months of age. Significant behavioral differences between age groups (2–3-, 4–5-, 6–7-, and 8–12-month-old groups) were found in all the behavioral tests, including the light/dark transition, open field, elevated plus maze, rotarod, social interaction, prepulse inhibition, Porsolt forced swim, tail suspension, Barnes maze, and fear conditioning tests, except for the hot plate test. Compared with the 2–3-month-old group, the 4–5- and 6–7-month-old groups exhibited decreased locomotor activity to novel environments, motor function, acoustic startle response, social behavior, and depression-related behavior, increased prepulse inhibition, and deficits in spatial and cued fear memory. For most behaviors, the 8–12-month-old group showed similar but more pronounced changes in most of these behaviors compared with the younger age groups. Older groups exhibited increased anxiety-like behavior in the light/dark transition test whereas those groups showed seemingly decreased anxiety-like behavior measured by the elevated plus maze test. The large-scale analysis of behavioral data from our battery of behavioral tests indicated age-related changes in a wide range of behaviors from young adulthood to middle age in C57BL/6J mice, though these results might have been influenced by possible confounding factors such as the time of day at testing and prior test experience. Our results also indicate that relatively narrow age differences can produce significant behavioral differences during adulthood in mice. These findings provide an insight into our understanding of the neurobiological processes underlying brain function and behavior that are subject to age-related changes in early to middle life. The findings also indicate that age is one of the critical factors to be carefully considered when designing behavioral tests and interpreting behavioral differences that might be induced by experimental manipulations.

1 November 2001 in Cell
Verified
Journal Article
Closed access
HZHongkui Zeng
Hongkui Zeng
SCSumantra Chattarji
Sumantra Chattarji
MBMichaela Barbarosie
Michaela Barbarosie
LRLaure Rondi-Reig
Laure Rondi-Reig
BPBenjamin D. Philpot
Benjamin D. Philpot
STSusumu Tonegawa
Susumu Tonegawa

1 June 2009 in Cell
Verified
Journal Article
Open access
JNJin Nakatani
Jin Nakatani
KTKota Tamada
Kota Tamada
FHFumiyuki Hatanaka
Fumiyuki Hatanaka
SISatoko Ise
Satoko Ise
HOHisashi Ohta
Hisashi Ohta
TTToru Takumi
Toru Takumi
Substantial evidence suggests that chromosomal abnormalities contribute to the risk of autism. The duplication of human chromosome 15q11-13 is known to be the most frequent cytogenetic abnormality in autism. We have modeled this genetic change in mice by using chromosome engineering to generate a 6.3 Mb duplication of the conserved linkage group on mouse chromosome 7. Mice with a paternal duplication display poor social interaction, behavioral inflexibility, abnormal ultrasonic vocalizations, and correlates of anxiety. An increased MBII52 snoRNA within the duplicated region, affecting the serotonin 2c receptor (5-HT2cR), correlates with altered intracellular Ca(2+) responses elicited by a 5-HT2cR agonist in neurons of mice with a paternal duplication. This chromosome-engineered mouse model for autism seems to replicate various aspects of human autistic phenotypes and validates the relevance of the human chromosome abnormality. This model will facilitate forward genetics of developmental brain disorders and serve as an invaluable tool for therapeutic development.